Colgate-Palmolive Announces Quarterly Dividend Increase and Elects Christopher Boerner, Ph.D. to Board of Directors

{
  "signal_id": "f438c055-500d-4b02-983f-c65b2c9a091d",
  "signal_type": "news",
  "signal_subtype": "hires",
  "detected_at": "2026-03-12T20:30:00+00:00",
  "company": {
    "name": "Colgate-Palmolive",
    "domain": "colgatepalmolive.com"
  },
  "data": {
    "url": "https://www.businesswire.com/news/home/20260312455835/en/Colgate-Palmolive-Announces-Quarterly-Dividend-Increase-and-Elects-Christopher-Boerner-Ph.D.-to-Board-of-Directors",
    "title": "Colgate-Palmolive Announces Quarterly Dividend Increase and Elects Christopher Boerner, Ph.D. to Board of Directors",
    "contact": "Boerner",
    "excerpt": "Colgate-Palmolive announces quarterly dividend increase and elects Christopher Boerner, Ph.D. to Board of Directors.\n\nNEW YORK-(BUSINESS WIRE)-The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today announced an increase in the quarterly common stock cash dividend to $0.53 up from $0.52 per share. The increase will be effective in the second quarter, 2026. The Board declared that the second quarter dividend is to be paid on May 15, 2026, to shareholders of record on April 20, 2026. On an annualized basis, the new dividend rate is $2.12 versus $2.08 per share previously. The Company has paid uninterrupted dividends on its common stock since 1895.\n\nSeparately, the Company also announced today that Christopher Boerner, Ph.D., Board Chair and Chief Executive Officer of Bristol-Myers Squibb Company (\"Bristol Myers Squibb\"), has been elected to Colgate-Palmolive's Board of Directors effective March 15, 2026.\n\nDr. Boerner, 55, has served as Chief Executive Officer of Bristol Myers Squibb, a global biopharmaceutical company, since November 2023 and as Board Chair since April 2024 and will bring extensive global business leadership experience and expertise in the pharmaceutical and healthcare industries, complementary industries, to Colgate-Palmolive's Board. He previously served as Executive Vice President, Chief Operating Officer of Bristol Myers Squibb in 2023 and as...",
    "summary": "Colgate-Palmolive Company hires Boerner as Chief Executive Officer.",
    "category": "hires",
    "found_at": "2026-03-12T20:30:00Z",
    "planning": false,
    "image_url": "https://mms.businesswire.com/media/20260312455835/en/2745790/22/New_Logo_Colgate_Palmolive_Company_Horiz_RGB_rev.jpg",
    "job_title": "Chief Executive Officer",
    "confidence": 0.5648,
    "published_at": "2026-03-12T20:30:00Z",
    "job_title_tags": [
      "directors"
    ],
    "article_sentence": "Dr. Boerner, 55, has served as Chief Executive Officer of Bristol Myers Squibb, a global biopharmaceutical company, since November 2023 and as Board Chair since April 2024 and will bring extensive global business leadership experience and expertise in the pharmaceutical and healthcare industries, complementary industries, to Colgate-Palmolive's Board."
  }
}

curl https://signals.autobound.ai/v1/signals/f438c055-500d-4b02-983f-c65b2c9a091d \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"colgatepalmolive.com","limit":20}'